Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05507515 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study of ONO-2020 in Healthy Participants
A Phase 1 study, sponsored by Ono Pharmaceutical Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 132
- Enrollment target
NCT05507515 is a Phase 1 study that has completed, run by Ono Pharmaceutical Co.. The registered enrollment target is 132 participants.
The verdict
NCT05507515, a Phase 1 study, has completed, sponsored by Ono Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this FIH study is to evaluate the safety, tolerability and pharmacokinetics of ONO-2020 in healthy adult participants. This FIH study consists of five parts (Parts A-E) to study single or multiple doses of ONO-2020 in healthy participants, including elderly and Japanese participants, as well as the food effect on the PK of ONO-2020. These data will support the clinical development program and help inform dose selection in future studies.
Interventions
- DRUG Placebo
- DRUG ONO-2020
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2022-07-29 |
| Est. Completion | 2023-12-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05507515
The ClinicalTrials.gov registry entry for NCT05507515 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharmaceutical Co., which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05507515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05507515 about?
NCT05507515 is a clinical study titled "A Phase 1 Study of ONO-2020 in Healthy Participants". The purpose of this FIH study is to evaluate the safety, tolerability and pharmacokinetics of ONO-2020 in healthy adult participants. This FIH study consists of five parts (Parts A-E) to study single or multiple doses of ONO-2020 in healthy participants, including elderly and Japanese participants, ...
What is the current status of trial NCT05507515?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 132 participants. The study started on 2022-07-29. Estimated completion is 2023-12-24.
What interventions are being tested in trial NCT05507515?
The interventions under investigation include: Placebo (DRUG), ONO-2020 (DRUG).
Who is sponsoring clinical trial NCT05507515?
This trial is sponsored by Ono Pharmaceutical Co., which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.